1. Volodymyr Probachai
Information acquired: 2025
Volodymyr Probachai is an academic who published a paper in 2017-11-16 entitled Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial. The paper was published in a journal entitled Lancet (London, England).